Physician profile
Brian Robinson
NPI 1821063413
$1,865.64
in general payments reported to CMS, 2019-2025
16 companies · $509 in 2025
The $509 reported for 2025 was less than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $139 · 2020: $42.86 · 2021: $15.91 · 2022: $182 · 2023: $300 · 2024: $677 · 2025: $509.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,486.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,485.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dexcom, INC. | $615.16 | 2019-2025 | Dexcom G6 Transmitter |
| Abbott Laboratories | $409.10 | 2021-2025 | Freestyle Libre |
| Novo Nordisk INC | $154.23 | 2023-2024 | Rybelsus, Ozempic, Wegovy |
| Insulet Corporation | $113.44 | 2020-2025 | Omnipod |
| Tandem Diabetes Care, INC. | $98.39 | 2019-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Amgen INC. | $83.77 | 2024 | Tepezza, Evenity, Prolia |
| Novartis Pharmaceuticals Corporation | $78.28 | 2023-2024 | |
| Astrazeneca Pharmaceuticals Lp | $76.79 | 2019-2020 | |
| Corcept Therapeutics | $61.80 | 2023-2024 | Korlym |
| Kyowa Kirin, INC. | $54.56 | 2023-2024 | Crysvita |
| Sequel Med Tech, LLC | $43.16 | 2025 | Twiist |
| Medtronic, INC. | $17.74 | 2023 | Minimed 780g |
| Sanofi-Aventis U.S. LLC | $16.85 | 2023 | |
| Abbvie INC. | $16.22 | 2023 | Synthroid |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.44 | 2024 | Jardiance |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $11.71 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Robinson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.